U.S. Personal Products Stock News

Keysight Technologies (KEYS) is back in focus after its CES 2026 showcase of an end to end live NR NTN connection in band n252 using Samsung’s next generation modem chipset, a step with clear industry implications. See our latest analysis for Keysight Technologies. The recent CES announcements land against a backdrop where Keysight’s share price has reached US$208.73, with a 90 day share price return of 26.63% and a 1 year total shareholder return of 29.56%. This suggests momentum has been...

PagSeguro Digital Ltd. has approved a special cash dividend of US$0.12 per common share, to be paid on February 27, 2026 to shareholders of record on January 28, 2026, subject to market and company financial conditions. This special distribution highlights the company’s use of excess capital to reward shareholders, complementing its existing focus on buybacks and capital efficiency. We’ll now examine how this special dividend decision fits into PagSeguro Digital’s broader investment...

In early January 2026, comments from President Donald Trump about lifting the U.S. military budget from about US$900 billion to US$1.50 trillion, together with the Federal Communications Commission’s ban on Chinese drone makers DJI and Autel, boosted investor attention on U.S.-based drone provider Red Cat Holdings. This combination of higher anticipated defense spending and regulatory support for domestic suppliers highlights how policy shifts can quickly reshape the competitive landscape...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

According to a new report by BCC Research, emerging AI technologies such as generative AI, edge AI, and quantum machine learning are driving transformative changes across various sectors, including healthcare, finance, logistics, and media. These innovations are enabling organizations to achieve a competitive edge by integrating more efficient and smarter solutions into their operations. The analysis highlights how AI applications are addressing real-world problems, with a focus on practical...

You may think that with a price-to-sales (or "P/S") ratio of 9.9x Senseonics Holdings, Inc. ( NASDAQ:SENS ) is a stock...

Newmark Group (NMRK) is in focus after arranging a 1.4 million square foot industrial lease for DrinkPAK at The Bellwether District in Philadelphia, one of the largest industrial deals in the city’s history. See our latest analysis for Newmark Group. That Bellwether District lease sits against a mixed recent run for the stock, with the share price at US$17.41 and a 1-year total shareholder return of 45.42%. The 90-day share price return of a 5.43% decline suggests some momentum has cooled,...

Planet Fitness (PLNT) drew investor attention after releasing year-end 2025 updates, highlighting membership of about 20.8 million, 181 new club openings, and a 6.7% rise in system-wide same-club sales. See our latest analysis for Planet Fitness. The latest membership and club rollout update comes after a mixed year for the stock, with a 90 day share price return of 6.19% but a 1 year total shareholder return decline of 0.95%. This suggests momentum has recently cooled despite longer term...

In recent months, Philip Morris International has been highlighted by Fundsmith Equity Fund and other commentators for its push into reduced-risk products such as IQOS heat‑not‑burn devices and nicotine pouches, while also declaring a regular quarterly dividend ahead of its fiscal Q4 2025 earnings release. An interesting angle is how institutional recognition of its smoke‑free innovation is coinciding with ongoing investment and regulatory scrutiny around the pace and profitability of its...

KLA Corporation recently reported stronger-than-expected earnings and increased guidance while opening a new AI-focused R&D and Innovation Center in Chennai, underscoring its emphasis on process control technologies for advanced semiconductor manufacturing. The combination of reinforced confidence in KLA’s competitive position and its expanded AI and software capabilities highlights how closely its technology roadmap is tied to long-term chipmaking complexity trends. Next, we will examine...

Recent insider selling at C3.ai (AI), including sizable disposals by founder Thomas Siebel and other executives, has coincided with weak billings growth, continued operating losses, and a sharp 61% share price decline in 2025. See our latest analysis for C3.ai. C3.ai’s recent insider selling and management changes come after a sharp 61% share price decline in 2025, with the latest close at $14.15 and a 1 year total shareholder return of 54.3% loss. This suggests sentiment has weakened despite...

Why Rubrik stock is back on investors’ radar Recent analyst coverage and revised opinions have put Rubrik (RBRK) in the spotlight again, as investors weigh its growth profile against ongoing questions around margins, valuation, and the durability of recent efficiency gains. See our latest analysis for Rubrik. Rubrik’s share price has cooled in recent months, with a 30 day share price return of 12.46% decline and a year to date share price return of 5.43% decline, even as the one year total...

In early January 2026, Cadence Design Systems unveiled a Chiplet Spec-to-Packaged Parts ecosystem, partnering with Arm, Samsung Foundry and several IP vendors to simplify chiplet design for physical AI, data center and high-performance computing applications, supported by a silicon prototype on Samsung’s SF5A process. An interesting aspect is Cadence’s move to offer a pre-integrated, silicon-validated chiplet platform that aims to cut engineering complexity and adoption risk for customers...

In early January 2026, Insmed reaffirmed its 2025 revenue guidance at US$606.4 million versus US$363.7 million a year earlier, highlighting strong contributions from ARIKAYCE and newly launched BRINSUPRI. Alongside this, the company outlined a packed 2026 roadmap, with European Commission approval of BRINSUPRI and multiple late-stage trial readouts that could reshape its respiratory and rare-disease portfolio. We’ll now examine how this sharp revenue step-up and BRINSUPRI’s European approval...

Alvotech (ALVO) has secured a $100 million senior term loan facility led by GoldenTree Asset Management. The financing is aimed at supporting liquidity and giving the company more flexibility as it advances its biosimilar pipeline and prepares upcoming launches. See our latest analysis for Alvotech. The funding deal and upcoming CEO transition arrive after a volatile period, with a 90 day share price return of a 45.10% decline and a 1 year total shareholder return of a 62.96% loss, suggesting...

Diamondback Energy recently disclosed in an 8-K filing that its realized oil price fell to US$58.00 per barrel in the fourth quarter, a 9.8% drop from the previous quarter alongside weaker natural gas pricing, which is likely to weigh on reported revenue for that period. This pullback in commodity realizations offers investors a timely case study of how short-term pricing pressure interacts with Diamondback’s cost-focused, Permian Basin–centric business model. Next, we’ll examine how these...

CNO Financial Group recently reported quarterly revenue of US$964.9 million, up year on year and broadly in line with analyst expectations, while earnings per share exceeded forecasts even as book value per share fell short. The combination of an earnings beat and a prior analyst upgrade citing improved return on equity highlights how profitability trends are becoming a central focus for assessing CNO’s progress. Next, we’ll examine how the earnings beat and improving return on equity shape...

Leadership moves and fresh guidance at CorMedix CorMedix (CRMD) is drawing attention after naming CEO Joseph Todisco as Chairman and issuing 2026 revenue guidance of US$300 million to US$320 million, alongside appointing Mike Seckler as EVP & Chief Commercial Officer. See our latest analysis for CorMedix. The leadership changes and fresh 2026 revenue guidance arrive after a sharp pullback in CorMedix’s share price. The 7 day share price return shows a decline of 36.50% and the year to date...

Upbound Group (UPBD) has drawn fresh investor attention after recent share price moves, with the stock last closing at $19.21. That has many investors revisiting its fundamentals and valuation profile. See our latest analysis for Upbound Group. The latest share price of $19.21 comes after a 5.38% 1 month share price return and a 10.72% year to date share price return, but the 1 year total shareholder return of 28.99% decline and 5 year total shareholder return of 47.26% decline point to...

Rapport Therapeutics (RAPP) is back in focus after receiving FDA clearance to start Phase 3 trials of its lead candidate RAP-219 in focal onset seizures, alongside updates across its broader central nervous system pipeline. See our latest analysis for Rapport Therapeutics. Despite the positive FDA update and broader pipeline progress, Rapport Therapeutics’ recent share price performance has been softer, with a 1 month share price return of 10.8% and a 7 day share price return of 2.39%. Its 1...

SEALSQ stock moves draw attention as returns diverge across timeframes SEALSQ (LAES) has been on traders’ radar after delivering a 4.6% move over the past day and a 3.3% gain over the past week, in contrast with a roughly 42% decline in the past 3 months. See our latest analysis for SEALSQ. Set against a 1 year total shareholder return of 18.85%, SEALSQ’s recent 1 day and 7 day share price gains hint at interest picking up again after a weaker 90 day share price return. If SEALSQ has caught...

Why AECOM’s recent share performance is drawing attention AECOM (ACM) is back on investor radars after a 13% six month share loss, softer quarterly results, a 2.7% average annual backlog decline, and analyst expectations for a 5.3% revenue drop. See our latest analysis for AECOM. While AECOM’s 24.98% 90 day share price decline and 7.39% 1 year total shareholder return loss point to fading momentum in the short term, its 92.45% 5 year total shareholder return shows that longer term holders...

Why Concentra Group Holdings Parent (CON) is Back on Investor Radars Concentra Group Holdings Parent (CON) is drawing fresh attention after management underlined its role in treating about one in four U.S. workplace injuries and operating more than 1,000 locations with stable, employer driven pricing. See our latest analysis for Concentra Group Holdings Parent. At a latest share price of US$20.61, Concentra has seen a 6.18% year to date share price return, with a 5.91% 7 day move suggesting...

SharpLink Gaming (SBET) has drawn fresh attention after reporting over US$33 million in income from staking its large Ethereum holdings and deploying an additional US$170 million of ether into Consensys' Linea network. See our latest analysis for SharpLink Gaming. The Ethereum treasury news lands after a mixed year for investors, with a 1 year total shareholder return of 78.12% contrasting with a 32.28% 3 month share price decline and a more modest year to date share price gain of 5.88%,...